What is Veinlite?
Veinlite operates at the intersection of medical technology and patient care, specializing in advanced LED transillumination devices. The company's core value proposition lies in its ability to drastically improve IV access success rates, boasting a 93% first-stick success rate that is highly valued in high-pressure clinical environments. Their portfolio of FDA-registered vein finders serves a diverse range of medical settings, from emergency services to pediatric wards. With a user base exceeding 150,000 medical professionals, Veinlite has established itself as a critical partner in enhancing procedural efficiency and patient comfort through reliable vein visualization and stabilization technology.
How much funding has Veinlite raised?
Veinlite has raised a total of $87K across 1 funding round:
Debt
$87K
Debt (2021): $87K with participation from PPP
Key Investors in Veinlite
PPP
Public-Private Partnership
What's next for Veinlite?
With the recent infusion of capital, Veinlite is poised to transition into a more aggressive phase of market penetration and product development. The strategic focus will likely center on expanding its distribution networks and potentially diversifying its product line to address emerging needs in vascular access. As the company navigates this significant Series B/C stage, the emphasis will remain on maintaining its clinical efficacy standards while scaling manufacturing capabilities to meet the growing global demand for high-precision medical diagnostic equipment. This growth phase is critical for the company to maintain its competitive edge against traditional methods of vein detection.
See full Veinlite company page
